Intervention Review

Estrogen for schizophrenia

  1. Wan Lian LC Chua1,*,
  2. Angelica Izquierdo de Santiago2,
  3. Jayashri Kulkarni3,
  4. Ann Mortimer4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 OCT 2005

DOI: 10.1002/14651858.CD004719.pub2


How to Cite

Chua WLLC, Izquierdo de Santiago A, Kulkarni J, Mortimer A. Estrogen for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD004719. DOI: 10.1002/14651858.CD004719.pub2.

Author Information

  1. 1

    Lynfield Hospital, Craven and Airedale Drugs and Alcohol Team, Bradford, West Yorkshire, UK

  2. 2

    The Mount, Leeds, West Yorkshire, UK

  3. 3

    Monash University, Alfred Psychiatry Research Centre (APRC), Melbourne, Australia

  4. 4

    University of Hull, Department of Psychiatry, Hull, East Yorkshire, UK

*Wan Lian LC Chua, Craven and Airedale Drugs and Alcohol Team, Lynfield Hospital, 25-27 Henry Street, Bradford, West Yorkshire, BD21 3DR, UK. Lian.Chua@bdct.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 OCT 2005

SEARCH

  1. Current Version

    Estrogen for schizophrenia

    Wan Lian LC Chua, Angelica Izquierdo de Santiago, Jayashri Kulkarni and Ann Mortimer

    Version of Record online: 19 OCT 2005 | DOI: 10.1002/14651858.CD004719.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Oestrogen for schizophrenia

    Wan Lian Chua, Angelica Izquierdo de Santiago, Jayashri Kulkarni and Ann Mortimer

    Version of Record online: 26 JAN 2004 | DOI: 10.1002/14651858.CD004719